Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 20/20 | 1.00 |
| ▸ | CDK4 | P11802 | 15/20 | 0.79 |
| ▸ | AURKA | O14965 | 5/20 | 0.79 |
| ▸ | CDK1 | P06493 | 4/20 | 0.79 |
| ▸ | CDK7 | P50613 | 4/20 | 0.79 |
| ▸ | CDK9 | P50750 | 4/20 | 0.79 |
| ▸ | AURKB | Q96GD4 | 4/20 | 0.79 |
| ▸ | PLK1 | P53350 | 2/20 | 0.77 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12589637 | 0.89 | CDK2 (0.82) | CDK2CDK4AURKACDK1CDK7 | |
| SCHEMBL6156894 | 0.88 | CDK2 (0.80) | CDK2CDK4AURKACDK1CDK7 | |
| SCHEMBL2073680 | 0.87 | CDK2 (0.78) | CDK2CDK4AURKACDK1CDK7 | |
| SCHEMBL6157812 | 0.87 | CDK2 (0.79) | CDK2CDK4AURKACDK1CDK7 | |
| SCHEMBL6160035 | 0.87 | CDK2 (1.00) | CDK2CDK4AURKACDK1CDK7 | |
| SCHEMBL6158693 | 0.87 | CDK2 (0.79) | CDK2CDK4AURKACDK1CDK7 | |
| SCHEMBL2289103 | 0.87 | CDK2 (1.00) | CDK2CDK4AURKACDK1CDK7 | |
| SCHEMBL2075942 | 0.87 | CDK2 (1.00) | CDK2CDK4AURKACDK1CDK7 | |
| SCHEMBL2284091 | 0.86 | CDK2 (1.00) | CDK2CDK4AURKACDK1CDK7 | |
| SCHEMBL2288706 | 0.86 | CDK2 (0.78) | CDK2CDK4AURKACDK1CDK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4576552-A1 | POWER CONVERTER | Delta Electronics, Inc. (TW) | 2025-06-25 | — | — | EP | claimed |
| CN-119967671-A | Afterglow eliminating circuit | 浙江凯耀照明有限责任公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119909064-A | Cystamine derivative or salt thereof and application thereof in preparation of medicines with antioxidation effect | 北京大学深圳研究生院 | 2025-05-02 | — | — | CN | claimed |
| US-20250091966-A1 | Silicate Solubilizing Streptomyces Sp. CS13-6 and Uses Thereof | INSTITUTE OF BIOLOGY, HEBEI ACADEMY OF SCIENCE (CN) | 2025-03-20 | — | — | US | claimed |
| EP-4517753-A1 | METADATA AND USER DATA STORAGE IN DIFFERENT BANKS | Samsung Electronics Co., Ltd (KR) | 2025-03-05 | — | — | EP | claimed |
| US-20240251664-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-25 | — | — | US | claimed |
| CN-113852373-B | Successive approximation type analog-to-digital converter with pipeline domino structure | 西安电子科技大学 | 2024-07-12 | — | — | CN | claimed |
| WO-2024051151-A1 | SILICON-RELEASING STREPTOMYCES CS13-6 AND USE THEREOF | 河北省科学院生物研究所 | 2024-03-14 | — | — | WO | claimed |
| CN-117070375-B | Composite microbial agent and application thereof in ecological restoration of soil | 河北省科学院生物研究所 | 2024-02-06 | — | — | CN | claimed |
| CN-117070375-A | Composite microbial agent and application thereof in ecological restoration of soil | 河北省科学院生物研究所 | 2023-11-17 | — | — | CN | claimed |
| CN-216600136-U | Two-way color temperature switching equalization circuit | 宁波凯耀电器制造有限公司 | 2022-05-24 | — | — | CN | claimed |
| CN-216356471-U | Power supply conversion circuit for high noise suppression audio conversion controller | 西安赛普特信息科技有限公司 | 2022-04-19 | — | — | CN | claimed |
| US-20050288307-A1 | Anti-viral compounds | CYCLACEL LIMITED (GB) | 2005-12-29 | — | — | US | claimed |
| EP-1581231-A1 | ANTI-VIRAL COMPOUNDS | Cyclacel Limited (GB) | 2005-10-05 | — | — | EP | claimed |
| WO-2004043467-A1 | ANTI-VIRAL COMPOUNDS | CYCLACEL LIMITED (GB) | 2004-05-27 | — | — | WO | claimed |
| US-20030149057-A1 | Anti-cancer compounds | CYCLACEL LIMITED (GB) | 2003-08-07 | — | — | US | claimed |
| US-6531479-B2 | Anticancer agents, skin disorders | CYCLACEL LIMITED (GB) | 2003-03-11 | — | — | US | claimed |
| EP-1274705-A1 | 2-SUBSTITUTED 4-HETEROARYL-PYRIMIDINES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS | Cyclacel Limited (GB) | 2003-01-15 | — | — | EP | claimed |
| US-20020019404-A1 | Anti-cancer compounds | CYCLACEL LIMITED (GB) | 2002-02-14 | — | — | US | claimed |
| WO-2001072745-A1 | 2-SUBSTITUTED 4-HETEROARYL-PYRIMIDINES AND THEIR USE IN THE TREATMETN OF PROLIFERATIVE DISORDERS | CYCLACEL LIMITED (GB) | 2001-10-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019404-A1 | Anti-cancer compounds | CDK3, CDK2, CDK4 | CDK2 2/4885CDK4 3/4885AURKA 85/4885 |
| US-20030149057-A1 | Anti-cancer compounds | CDK3, CDK2, CDK4 | CDK2 2/4885CDK4 3/4885AURKA 85/4885 |
| US-20240251664-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | NES, NFE2L2, NUCB2 | CDK2 1219/4885CDK4 2213/4885AURKA 1164/4885 |
| US-20050288307-A1 | Anti-viral compounds | MAVS, HAVCR2, EIF2AK2 | CDK2 205/4885CDK4 477/4885AURKA 3011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.